Literature DB >> 15877311

Depression, cytokines, and glial function.

Diane B Miller1, James P O'Callaghan.   

Abstract

It has been known for some time that cytokines made and released during systemic illness can result in a constellation of symptoms strikingly similar to those observed in depression. The overlap of the symptoms of depression and systemic illness raises the intriguing possibility that cytokines may be involved in the development and maintenance of mood disorders. Cytokines are small ubiquitous pleiotropic molecules that are made and released in response to a variety of stimuli. They have a multitude of actions throughout the body, including actions on the central and peripheral nervous systems. Alterations in the levels of circulating cytokines, especially the key proinflammatory cytokines, interleukin 6 and tumor necrosis factor alpha , have been linked to a variety of disease states including those involving central nervous system depression. In this brief review, epidemiological and clinical data on depression, as well as findings from relevant animal models, are examined for links between cytokine expression and depression. We suggest that glial cells, both as a source and target of cytokines, represent the overlooked targets involved in the etiology of depression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15877311     DOI: 10.1016/j.metabol.2005.01.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

Review 1.  Astrogliosis.

Authors:  Michael V Sofroniew
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-11-07       Impact factor: 10.005

Review 2.  Astrocyte barriers to neurotoxic inflammation.

Authors:  Michael V Sofroniew
Journal:  Nat Rev Neurosci       Date:  2015-05       Impact factor: 34.870

3.  Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6.

Authors:  T E Nelson; A Olde Engberink; R Hernandez; A Puro; S Huitron-Resendiz; C Hao; P N E De Graan; D L Gruol
Journal:  Brain Behav Immun       Date:  2012-05-17       Impact factor: 7.217

Review 4.  Neuroinflammation disorders exacerbated by environmental stressors.

Authors:  James P O'Callaghan; Diane B Miller
Journal:  Metabolism       Date:  2019-11       Impact factor: 8.694

5.  Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households.

Authors:  Leslie K Serchuck; Paige L Williams; Sharon Nachman; Kenneth D Gadow; Miriam Chernoff; Lynnae Schwartz
Journal:  AIDS Care       Date:  2010-05

6.  Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report.

Authors:  Sriram Yennurajalingam; Janet L Williams; Gary Chisholm; Eduardo Bruera
Journal:  Oncologist       Date:  2016-02-17

Review 7.  The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.

Authors:  Maria Gulinello; Chaim Putterman
Journal:  J Biomed Biotechnol       Date:  2011-02-10

8.  Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide.

Authors:  Alice F Viana; Izaque S Maciel; Fabiana N Dornelles; Claudia P Figueiredo; Jarbas M Siqueira; Maria M Campos; João B Calixto
Journal:  J Neuroinflammation       Date:  2010-12-31       Impact factor: 8.322

9.  A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study.

Authors:  Marzieh Majd; Farshad Hashemian; Seyed Mohammad Hosseini; Maryam Vahdat Shariatpanahi; Ali Sharifi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

10.  Increased astrocyte expression of IL-6 or CCL2 in transgenic mice alters levels of hippocampal and cerebellar proteins.

Authors:  Donna L Gruol; Khanh Vo; Jennifer G Bray
Journal:  Front Cell Neurosci       Date:  2014-08-14       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.